Ganoderma lucidum polysaccharides alleviate non-alcoholic fatty liver disease by modulating gut microbiota against TLR4/NF-κB/MAPK pathway and activating AMPK pathway.

Ganoderma lucidum

OncologyImmune supportMetabolic healthGut & microbiome

SpeciesReishi, Lingzhi

JournalJournal of ethnopharmacology

Year2026

Metadata-grounded summary

Article summary

Metadata-grounded summary: This journal article indexes research on Ganoderma lucidum in Journal of ethnopharmacology in 2026. MycoData maps the paper to oncology, immune support, metabolic health, gut & microbiome based on its title, species context, article metadata, and study classification.

Citation

Zhao H, Li Y, Liu N, Chen P, Yu X, Li G, et al. (2026). Ganoderma lucidum polysaccharides alleviate non-alcoholic fatty liver disease by modulating gut microbiota against TLR4/NF-κB/MAPK pathway and activating AMPK pathway. Journal of ethnopharmacology https://doi.org/10.1016/j.jep.2025.120723 PMID: 41067318

Open citation